Literature DB >> 22186947

Matrix metalloproteinase levels in peritoneal effluents were increased in a patient with appendicitis undergoing continuous ambulatory peritoneal dialysis.

Yutaka Takezawa1, Yoshitaka Saitou, Tatsuya Uchida, Ichiro Hirahara, Eiji Kusano, Mikio Kobayashi.   

Abstract

A differential diagnosis of common bacterial peritonitis and appendicitis is difficult in continuous ambulatory peritoneal dialysis (CAPD) patients, and thus the definite diagnosis of appendicitis is often delayed. In this case, a 60-year-old man undergoing CAPD was at first diagnosed with bacterial peritonitis but not appendicitis, and antibiotics were administered. The number of leukocytes in the peritoneal effluent decreased mildly, but the level of C-reactive protein continued to be high and the pain aggravated. When the catheter was removed, suppurative appendicitis was confirmed for the first time. Levels of matrix metalloproteinase (MMP)-2 and -9 in peritoneal effluents were markedly high. Appendicitis should be diagnosed as early as possible because MMPs directly injure the peritoneum via degradation of extracellular matrix proteins. Future studies in a greater numbers of cases of appendicitis are required.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186947     DOI: 10.1007/s10157-011-0576-0

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  12 in total

1.  Emergency laparotomy in patients on continuous ambulatory peritoneal dialysis.

Authors:  C Carmeci; W Muldowney; S A Mazbar; R Bloom
Journal:  Am Surg       Date:  2001-07       Impact factor: 0.688

2.  Peritoneal injury by methylglyoxal in peritoneal dialysis.

Authors:  Ichiro Hirahara; Eiji Kusano; Satoru Yanagiba; Yukio Miyata; Yasuhiro Ando; Shigeaki Muto; Yasushi Asano
Journal:  Perit Dial Int       Date:  2006 May-Jun       Impact factor: 1.756

3.  An uncommon case of peritonitis: appendicitis should not be overlooked.

Authors:  Fabrice Mihout; Célia Lessoré de Sainte Foy; Laurence Vrigneaud; Frédéric Wallet; Dominique Pagniez; Eric Boulanger
Journal:  Perit Dial Int       Date:  2007 May-Jun       Impact factor: 1.756

4.  Appendicitis in a CAPD patient: a diagnostic challenge.

Authors:  Chih-Yu Yang; Chiao-Lin Chuang; Shu-Huei Shen; Tzen-Wen Chen; Wu-Chang Yang; Jinn-Yang Chen
Journal:  Perit Dial Int       Date:  2007 Sep-Oct       Impact factor: 1.756

5.  A case of encapsulating peritoneal sclerosis at the clinical early stage with high concentration of matrix metalloproteinase-2 in peritoneal effluent.

Authors:  Yoshinori Masunaga; Ichiro Hirahara; Yasumasa Shimano; Megumi Kurosu; Osamu Iimura; Yukio Miyata; Morimasa Amemiya; Sumiko Homma; Eiji Kusano; Yasushi Asano
Journal:  Clin Exp Nephrol       Date:  2005-03       Impact factor: 2.801

Review 6.  Appendicitis at the millennium.

Authors:  B A Birnbaum; S R Wilson
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

7.  The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.

Authors:  Ichiro Hirahara; Makoto Inoue; Kousuke Okuda; Yasuhiro Ando; Shigeaki Muto; Eiji Kusano
Journal:  Nephrol Dial Transplant       Date:  2006-10-11       Impact factor: 5.992

8.  A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis.

Authors:  Anna Solberg; Lena Holmdahl; Peter Falk; Ingrid Palmgren; Marie-Louise Ivarsson
Journal:  Int J Colorectal Dis       Date:  2008-03-18       Impact factor: 2.571

9.  CRP in acute appendicitis--is it a necessary investigation?

Authors:  T Amalesh; M Shankar; R Shankar
Journal:  Int J Surg       Date:  2004       Impact factor: 6.071

10.  T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency.

Authors:  J L Touraine; F Touraine; J P Revillard; J Brochier; J Traeger
Journal:  Nephron       Date:  1975       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.